Maternal Thyroid Diseases, Medication Use and Childhood Cancer Risks in Offspring: A Population‐Based Cohort Study in Denmark
Chuanjie Deng, Kosuke Inoue, Chai Saechao, Johnni Hansen, Beate Ritz, Julia E Heck · 2026
Read Maternal Thyroid Diseases, Medication Use and Childhood Cancer Risks in Offspring: A Population‐Based Cohort Study in Denmark by Chuanjie Deng, Kosuke Inoue, Chai Saechao, Johnni Hansen, Beate Ritz, Julia E Heck (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13495921.txt.
Description
Deng and co-authors use Denmark's national registries to ask whether a mother's thyroid disease, or the medicines used for it, raises her child's risk of cancer. Thyroid problems are common in women of childbearing age, but earlier evidence was patchy. Their 2026 case-control study matched 2,521 children diagnosed with cancer between 1973 and 2016 against 63,014 children without cancer. It then pulled mothers' diagnoses and prescriptions from national registers.
One condition stood out: children of mothers with goiter, an enlarged thyroid, had roughly double the odds of any childhood cancer in the adjusted analysis. Higher odds again appeared for leukaemia and lymphoma in particular. Neither underactive nor overactive thyroid showed a clear link, though the authors caution those analyses had limited statistical power. Reassuringly, mothers' thyroid medication itself carried no increased risk. The team stresses the small numbers behind the goiter finding and calls for replication first.
Catalog record
| CREATOR | Chuanjie Deng, Kosuke Inoue, Chai Saechao, Johnni Hansen, Beate Ritz, Julia E Heck |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 27 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |